Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 200 of 315

1.

Change in Fitness and the Relation to Change in Cognition and Neuropsychiatric Symptoms After Aerobic Exercise in Patients with Mild Alzheimer's Disease.

Sobol NA, Dall CH, Høgh P, Hoffmann K, Frederiksen KS, Vogel A, Siersma V, Waldemar G, Hasselbalch SG, Beyer N.

J Alzheimers Dis. 2018;65(1):137-145. doi: 10.3233/JAD-180253.

2.

Validation of the Rowland Universal Dementia Assessment Scale (RUDAS) in a multicultural sample across five Western European countries: diagnostic accuracy and normative data.

Nielsen TR, Segers K, Vanderaspoilden V, Bekkhus-Wetterberg P, Bjørkløf GH, Beinhoff U, Minthon L, Pissiota A, Tsolaki M, Gkioka M, Waldemar G.

Int Psychogeriatr. 2018 Jul 18:1-10. doi: 10.1017/S1041610218000832. [Epub ahead of print]

PMID:
30017010
3.

EEG Theta Power Is an Early Marker of Cognitive Decline in Dementia due to Alzheimer's Disease.

Musaeus CS, Engedal K, Høgh P, Jelic V, Mørup M, Naik M, Oeksengaard AR, Snaedal J, Wahlund LO, Waldemar G, Andersen BB.

J Alzheimers Dis. 2018;64(4):1359-1371. doi: 10.3233/JAD-180300.

PMID:
29991135
4.

Data-Driven Differential Diagnosis of Dementia Using Multiclass Disease State Index Classifier.

Tolonen A, Rhodius-Meester HFM, Bruun M, Koikkalainen J, Barkhof F, Lemstra AW, Koene T, Scheltens P, Teunissen CE, Tong T, Guerrero R, Schuh A, Ledig C, Baroni M, Rueckert D, Soininen H, Remes AM, Waldemar G, Hasselbalch SG, Mecocci P, van der Flier WM, Lötjönen J.

Front Aging Neurosci. 2018 Apr 25;10:111. doi: 10.3389/fnagi.2018.00111. eCollection 2018.

5.

The process of disclosing a diagnosis of dementia and mild cognitive impairment: A national survey of specialist physicians in Denmark.

Nielsen TR, Svensson BH, Rohr G, Gottrup H, Vestergaard K, Høgh P, Waldemar G.

Dementia (London). 2018 Jan 1:1471301218777443. doi: 10.1177/1471301218777443. [Epub ahead of print]

PMID:
29806491
6.

Automatic MRI Quantifying Methods in Behavioral-Variant Frontotemporal Dementia Diagnosis.

Cajanus A, Hall A, Koikkalainen J, Solje E, Tolonen A, Urhemaa T, Liu Y, Haanpää RM, Hartikainen P, Helisalmi S, Korhonen V, Rueckert D, Hasselbalch S, Waldemar G, Mecocci P, Vanninen R, van Gils M, Soininen H, Lötjönen J, Remes AM.

Dement Geriatr Cogn Dis Extra. 2018 Feb 23;8(1):51-59. doi: 10.1159/000486849. eCollection 2018 Jan-Apr.

7.

Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease.

Mattsson N, Groot C, Jansen WJ, Landau SM, Villemagne VL, Engelborghs S, Mintun MM, Lleo A, Molinuevo JL, Jagust WJ, Frisoni GB, Ivanoiu A, Chételat G, Resende de Oliveira C, Rodrigue KM, Kornhuber J, Wallin A, Klimkowicz-Mrowiec A, Kandimalla R, Popp J, Aalten PP, Aarsland D, Alcolea D, Almdahl IS, Baldeiras I, van Buchem MA, Cavedo E, Chen K, Cohen AD, Förster S, Fortea J, Frederiksen KS, Freund-Levi Y, Gill KD, Gkatzima O, Grimmer T, Hampel H, Herukka SK, Johannsen P, van Laere K, de Leon MJ, Maier W, Marcusson J, Meulenbroek O, Møllergård HM, Morris JC, Mroczko B, Nordlund A, Prabhakar S, Peters O, Rami L, Rodríguez-Rodríguez E, Roe CM, Rüther E, Santana I, Schröder J, Seo SW, Soininen H, Spiru L, Stomrud E, Struyfs H, Teunissen CE, Verhey FRJ, Vos SJB, van Waalwijk van Doorn LJC, Waldemar G, Wallin ÅK, Wiltfang J, Vandenberghe R, Brooks DJ, Fladby T, Rowe CC, Drzezga A, Verbeek MM, Sarazin M, Wolk DA, Fleisher AS, Klunk WE, Na DL, Sánchez-Juan P, Lee DY, Nordberg A, Tsolaki M, Camus V, Rinne JO, Fagan AM, Zetterberg H, Blennow K, Rabinovici GD, Hansson O, van Berckel BNM, van der Flier WM, Scheltens P, Visser PJ, Ossenkoppele R.

Alzheimers Dement. 2018 Jul;14(7):913-924. doi: 10.1016/j.jalz.2018.02.009. Epub 2018 Mar 28.

PMID:
29601787
8.

Polypharmacy and Potentially Inappropriate Medication in People with Dementia: A Nationwide Study.

Kristensen RU, Nørgaard A, Jensen-Dahm C, Gasse C, Wimberley T, Waldemar G.

J Alzheimers Dis. 2018;63(1):383-394. doi: 10.3233/JAD-170905.

PMID:
29578483
9.

Performance of middle-aged and elderly European minority and majority populations on a Cross-Cultural Neuropsychological Test Battery (CNTB).

Nielsen TR, Segers K, Vanderaspoilden V, Bekkhus-Wetterberg P, Minthon L, Pissiota A, Bjørkløf GH, Beinhoff U, Tsolaki M, Gkioka M, Waldemar G.

Clin Neuropsychol. 2018 Jan 24:1-20. doi: 10.1080/13854046.2018.1430256. [Epub ahead of print]

PMID:
29364089
10.

Socio-demographic and cardiovascular disease risk factors associated with dementia: Results of a cross-sectional study from Lebanon.

Chaaya M, Phung K, Atweh S, El Asmar K, Karam G, Khoury RM, Ghandour L, Ghusn H, Assaad S, Prince M, Waldemar G.

Prev Med Rep. 2017 Nov 24;9:1-5. doi: 10.1016/j.pmedr.2017.11.006. eCollection 2018 Mar.

11.

Communicating Identifiability Risks to Biobank Donors.

Kasperbauer TJ, Gjerris M, Waldemar G, Sandøe P.

Camb Q Healthc Ethics. 2018 Jan;27(1):123-136. doi: 10.1017/S0963180117000457.

PMID:
29214966
12.

Social Relations at Work and Incident Dementia: 29-Years' Follow-Up of the Copenhagen Male Study.

Ishtiak-Ahmed K, Hansen ÅM, Garde AH, Mortensen EL, Gyntelberg F, Phung TKT, Lund R, Rod NH, Prescott E, Waldemar G, Westendorp R, Nabe-Nielsen K.

J Occup Environ Med. 2018 Jan;60(1):12-18. doi: 10.1097/JOM.0000000000001158.

13.

Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia.

Jansen WJ, Ossenkoppele R, Tijms BM, Fagan AM, Hansson O, Klunk WE, van der Flier WM, Villemagne VL, Frisoni GB, Fleisher AS, Lleó A, Mintun MA, Wallin A, Engelborghs S, Na DL, Chételat G, Molinuevo JL, Landau SM, Mattsson N, Kornhuber J, Sabri O, Rowe CC, Parnetti L, Popp J, Fladby T, Jagust WJ, Aalten P, Lee DY, Vandenberghe R, Resende de Oliveira C, Kapaki E, Froelich L, Ivanoiu A, Gabryelewicz T, Verbeek MM, Sanchez-Juan P, Hildebrandt H, Camus V, Zboch M, Brooks DJ, Drzezga A, Rinne JO, Newberg A, de Mendonça A, Sarazin M, Rabinovici GD, Madsen K, Kramberger MG, Nordberg A, Mok V, Mroczko B, Wolk DA, Meyer PT, Tsolaki M, Scheltens P, Verhey FRJ, Visser PJ; Amyloid Biomarker Study Group, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, Barthel H, van Berckel BNM, Blennow K, van Buchem MA, Cavedo E, Chen K, Chipi E, Cohen AD, Förster S, Fortea J, Frederiksen KS, Freund-Levi Y, Gkatzima O, Gordon MF, Grimmer T, Hampel H, Hausner L, Hellwig S, Herukka SK, Johannsen P, Klimkowicz-Mrowiec A, Köhler S, Koglin N, van Laere K, de Leon M, Lisetti V, Maier W, Marcusson J, Meulenbroek O, Møllergård HM, Morris JC, Nordlund A, Novak GP, Paraskevas GP, Perera G, Peters O, Ramakers IHGB, Rami L, Rodríguez-Rodríguez E, Roe CM, Rot U, Rüther E, Santana I, Schröder J, Seo SW, Soininen H, Spiru L, Stomrud E, Struyfs H, Teunissen CE, Vos SJB, van Waalwijk van Doorn LJC, Waldemar G, Wallin ÅK, Wiltfang J, Zetterberg H.

JAMA Psychiatry. 2018 Jan 1;75(1):84-95. doi: 10.1001/jamapsychiatry.2017.3391.

PMID:
29188296
14.

Effects of Physical Exercise on Alzheimer's Disease Biomarkers: A Systematic Review of Intervention Studies.

Frederiksen KS, Gjerum L, Waldemar G, Hasselbalch SG.

J Alzheimers Dis. 2018;61(1):359-372. doi: 10.3233/JAD-170567. Review.

PMID:
29154278
15.

Dementia and family burden of care in Lebanon.

Chaaya M, Phung K, Atweh S, El Asmar K, Karam G, Khoury R, Ghandour L, Ghusn H, Assaad S, Prince M, Waldemar G.

BJPsych Int. 2017 Feb 1;14(1):7-9. eCollection 2017 Feb.

16.

Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition.

Reijs BLR, Ramakers IHGB, Elias-Sonnenschein L, Teunissen CE, Koel-Simmelink M, Tsolaki M, Wahlund LO, Waldemar G, Hausner L, Johannsen P, Vanderstichele H, Verhey F, Devanand DP, Visser PJ.

J Alzheimers Dis. 2017;60(3):1025-1034. doi: 10.3233/JAD-170564.

PMID:
28984603
17.

Memory Correlates of Alzheimer's Disease Cerebrospinal Fluid Markers: A Longitudinal Cohort Study.

Reijs BLR, Ramakers IHGB, Köhler S, Teunissen CE, Koel-Simmelink M, Nathan PJ, Tsolaki M, Wahlund LO, Waldemar G, Hausner L, Vandenberghe R, Johannsen P, Blackwell A, Vanderstichele H, Verhey F, Visser PJ.

J Alzheimers Dis. 2017;60(3):1119-1128. doi: 10.3233/JAD-160766.

PMID:
28984585
18.

TMEM106B and ApoE polymorphisms in CHMP2B-mediated frontotemporal dementia (FTD-3).

Rostgaard N, Roos P, Budtz-Jørgensen E, Johannsen P, Waldemar G, Nørremølle A, Lindquist SG, Gydesen S, Brown JM, Collinge J, Isaacs AM; FReJA collaboration, Nielsen TT, Nielsen JE.

Neurobiol Aging. 2017 Nov;59:221.e1-221.e7. doi: 10.1016/j.neurobiolaging.2017.06.026. Epub 2017 Jul 11.

PMID:
28888721
19.

Current Approaches and Clinician Attitudes to the Use of Cerebrospinal Fluid Biomarkers in Diagnostic Evaluation of Dementia in Europe.

Miller AM, Balasa M, Blennow K, Gardiner M, Rutkowska A, Scheltens P, Teunissen CE, Visser PJ, Winblad B, Waldemar G, Lawlor B.

J Alzheimers Dis. 2017;60(1):201-210. doi: 10.3233/JAD-170502.

PMID:
28826189
20.

Self-rated versus Caregiver-rated Health for Patients with Mild Dementia as Predictors of Patient Mortality.

Phung TKT, Siersma V, Vogel A, Waldorff FB, Waldemar G.

Am J Geriatr Psychiatry. 2018 Mar;26(3):375-385. doi: 10.1016/j.jagp.2017.06.005. Epub 2017 Jun 7.

PMID:
28760512
21.

Shift work, long working hours, and later risk of dementia: A long-term follow-up of the Copenhagen Male Study.

Nabe-Nielsen K, Garde AH, Ishtiak-Ahmed K, Gyntelberg F, Mortensen EL, Phung TKT, Rod NH, Waldemar G, Westendorp RG, Hansen ÅM.

Scand J Work Environ Health. 2017 Nov 1;43(6):569-577. doi: 10.5271/sjweh.3660. Epub 2017 Jul 14.

PMID:
28707697
22.

Five-class differential diagnostics of neurodegenerative diseases using random undersampling boosting.

Tong T, Ledig C, Guerrero R, Schuh A, Koikkalainen J, Tolonen A, Rhodius H, Barkhof F, Tijms B, Lemstra AW, Soininen H, Remes AM, Waldemar G, Hasselbalch S, Mecocci P, Baroni M, Lötjönen J, Flier WV, Rueckert D.

Neuroimage Clin. 2017 Jun 12;15:613-624. doi: 10.1016/j.nicl.2017.06.012. eCollection 2017.

23.
24.

Dementia prevalence, care arrangement, and access to care in Lebanon: A pilot study.

Phung KTT, Chaaya M, Prince M, Atweh S, El Asmar K, Karam G, Khoury RM, Ghandour L, Ghusn H, Nielsen TR, Waldemar G.

Alzheimers Dement. 2017 Dec;13(12):1317-1326. doi: 10.1016/j.jalz.2017.04.007. Epub 2017 Jun 2.

PMID:
28579315
25.

Major Depressive Symptoms Increase 3-Year Mortality Rate in Patients with Mild Dementia.

Petersen JD, Waldorff FB, Siersma VD, Phung TKT, Bebe ACKM, Waldemar G.

Int J Alzheimers Dis. 2017;2017:7482094. doi: 10.1155/2017/7482094. Epub 2017 Apr 6.

26.

Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment.

Herukka SK, Simonsen AH, Andreasen N, Baldeiras I, Bjerke M, Blennow K, Engelborghs S, Frisoni GB, Gabryelewicz T, Galluzzi S, Handels R, Kramberger MG, Kulczyńska A, Molinuevo JL, Mroczko B, Nordberg A, Oliveira CR, Otto M, Rinne JO, Rot U, Saka E, Soininen H, Struyfs H, Suardi S, Visser PJ, Winblad B, Zetterberg H, Waldemar G.

Alzheimers Dement. 2017 Mar;13(3):285-295. doi: 10.1016/j.jalz.2016.09.009. Epub 2016 Oct 27. Review.

27.

Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia.

Simonsen AH, Herukka SK, Andreasen N, Baldeiras I, Bjerke M, Blennow K, Engelborghs S, Frisoni GB, Gabryelewicz T, Galluzzi S, Handels R, Kramberger MG, Kulczyńska A, Molinuevo JL, Mroczko B, Nordberg A, Oliveira CR, Otto M, Rinne JO, Rot U, Saka E, Soininen H, Struyfs H, Suardi S, Visser PJ, Winblad B, Zetterberg H, Waldemar G.

Alzheimers Dement. 2017 Mar;13(3):274-284. doi: 10.1016/j.jalz.2016.09.008. Epub 2016 Oct 27. Review.

28.

Ny national handlingsplan for demens.

Waldemar G.

Ugeskr Laeger. 2017 Mar 20;179(12). pii: V69163. Danish. No abstract available.

PMID:
28330537
29.

Psychotropic Polypharmacy in Patients with Dementia: Prevalence and Predictors.

Nørgaard A, Jensen-Dahm C, Gasse C, Hansen ES, Waldemar G.

J Alzheimers Dis. 2017;56(2):707-716. doi: 10.3233/JAD-160828.

PMID:
28035931
30.

Generation of a gene-corrected isogenic control cell line from an Alzheimer's disease patient iPSC line carrying a A79V mutation in PSEN1.

Pires C, Schmid B, Petræus C, Poon A, Nimsanor N, Nielsen TT, Waldemar G, Hjermind LE, Nielsen JE, Hyttel P, Freude KK.

Stem Cell Res. 2016 Sep;17(2):285-288. doi: 10.1016/j.scr.2016.08.002. Epub 2016 Aug 7.

31.

Cerebrospinal Fluid Amyloid Beta and Tau Concentrations Are Not Modulated by 16 Weeks of Moderate- to High-Intensity Physical Exercise in Patients with Alzheimer Disease.

Steen Jensen C, Portelius E, Siersma V, Høgh P, Wermuth L, Blennow K, Zetterberg H, Waldemar G, Gregers Hasselbalch S, Hviid Simonsen A.

Dement Geriatr Cogn Disord. 2016;42(3-4):146-158. Epub 2016 Sep 20.

PMID:
27643858
32.

Geographical Variation in Antipsychotic Drug Use in Elderly Patients with Dementia: A Nationwide Study.

Zakarias JK, Jensen-Dahm C, Nørgaard A, Stevnsborg L, Gasse C, Andersen BG, Søren J, Waldorff FB, Moos T, Waldemar G.

J Alzheimers Dis. 2016 Oct 4;54(3):1183-1192.

PMID:
27567863
33.

Inequalities in Access to Treatment and Care for Patients with Dementia and Immigrant Background: A Danish Nationwide Study.

Stevnsborg L, Jensen-Dahm C, Nielsen TR, Gasse C, Waldemar G.

J Alzheimers Dis. 2016 Sep 6;54(2):505-14. doi: 10.3233/JAD-160124.

PMID:
27567820
34.

Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a M146I mutation in PSEN1.

Li T, Pires C, Nielsen TT, Waldemar G, Hjermind LE, Nielsen JE, Dinnyes A, Holst B, Hyttel P, Freude KK.

Stem Cell Res. 2016 Mar;16(2):334-7. doi: 10.1016/j.scr.2016.01.001. Epub 2016 Jan 14.

35.

Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying an A79V mutation in PSEN1.

Li T, Pires C, Nielsen TT, Waldemar G, Hjermind LE, Nielsen JE, Dinnyes A, Hyttel P, Freude KK.

Stem Cell Res. 2016 Mar;16(2):229-32. doi: 10.1016/j.scr.2016.01.002. Epub 2016 Jan 14.

36.

Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a L150P mutation in PSEN-1.

Tubsuwan A, Pires C, Rasmussen MA, Schmid B, Nielsen JE, Hjermind LE, Hall V, Nielsen TT, Waldemar G, Hyttel P, Clausen C, Kitiyanant N, Freude KK, Holst B.

Stem Cell Res. 2016 Jan;16(1):110-2. doi: 10.1016/j.scr.2015.12.015. Epub 2015 Dec 28.

37.

Induced pluripotent stem cells (iPSCs) derived from a pre-symptomatic carrier of a R406W mutation in microtubule-associated protein tau (MAPT) causing frontotemporal dementia.

Rasmussen MA, Hjermind LE, Hasholt LF, Waldemar G, Nielsen JE, Clausen C, Hyttel P, Holst B.

Stem Cell Res. 2016 Jan;16(1):105-9. doi: 10.1016/j.scr.2015.12.012. Epub 2015 Dec 23.

38.

Induced pluripotent stem cells (iPSCs) derived from a patient with frontotemporal dementia caused by a R406W mutation in microtubule-associated protein tau (MAPT).

Rasmussen MA, Hjermind LE, Hasholt LF, Waldemar G, Nielsen JE, Clausen C, Hyttel P, Holst B.

Stem Cell Res. 2016 Jan;16(1):75-8. doi: 10.1016/j.scr.2015.12.006. Epub 2015 Dec 12.

39.

Induced pluripotent stem cells (iPSCs) derived from a patient with frontotemporal dementia caused by a P301L mutation in microtubule-associated protein tau (MAPT).

Rasmussen MA, Hjermind LE, Hasholt LF, Waldemar G, Nielsen JE, Clausen C, Hyttel P, Holst B.

Stem Cell Res. 2016 Jan;16(1):70-4. doi: 10.1016/j.scr.2015.12.008. Epub 2015 Dec 12.

40.

Effect of aerobic exercise on physical performance in patients with Alzheimer's disease.

Sobol NA, Hoffmann K, Frederiksen KS, Vogel A, Vestergaard K, Brændgaard H, Gottrup H, Lolk A, Wermuth L, Jakobsen S, Laugesen L, Gergelyffy R, Høgh P, Bjerregaard E, Siersma V, Andersen BB, Johannsen P, Waldemar G, Hasselbalch SG, Beyer N.

Alzheimers Dement. 2016 Dec;12(12):1207-1215. doi: 10.1016/j.jalz.2016.05.004. Epub 2016 Jun 23.

PMID:
27344641
41.

Early-Onset Dementia: Frequency, Diagnostic Procedures, and Quality Indicators in Three European Tertiary Referral Centers.

Konijnenberg E, Fereshtehnejad SM, Kate MT, Eriksdotter M, Scheltens P, Johannsen P, Waldemar G, Visser PJ.

Alzheimer Dis Assoc Disord. 2017 Apr-Jun;31(2):146-151. doi: 10.1097/WAD.0000000000000152.

PMID:
27158877
42.

Differential diagnosis of neurodegenerative diseases using structural MRI data.

Koikkalainen J, Rhodius-Meester H, Tolonen A, Barkhof F, Tijms B, Lemstra AW, Tong T, Guerrero R, Schuh A, Ledig C, Rueckert D, Soininen H, Remes AM, Waldemar G, Hasselbalch S, Mecocci P, van der Flier W, Lötjönen J.

Neuroimage Clin. 2016 Mar 5;11:435-49. doi: 10.1016/j.nicl.2016.02.019. eCollection 2016.

43.

Poor self-rated health did not increase risk of permanent nursing placement or mortality in people with mild Alzheimer's disease.

Nielsen AB, Siersma V, Waldemar G, Waldorff FB.

BMC Geriatr. 2016 Apr 19;16:87. doi: 10.1186/s12877-016-0262-x.

44.

[The risk of dementia and cognitive decline can be reduced].

Jørgensen K, Hasselbalch SG, Waldemar G.

Ugeskr Laeger. 2016 Feb 15;178(7):V11150887. Danish.

PMID:
27063006
45.

Differences in quantitative methods for measuring subjective cognitive decline - results from a prospective memory clinic study.

Vogel A, Salem LC, Andersen BB, Waldemar G.

Int Psychogeriatr. 2016 Sep;28(9):1513-20. doi: 10.1017/S1041610216000272. Epub 2016 Apr 7.

PMID:
27053171
46.

Postoperative Treatment of Pain after Hip Fracture in Elderly Patients with Dementia.

Jensen-Dahm C, Palm H, Gasse C, Dahl JB, Waldemar G.

Dement Geriatr Cogn Disord. 2016;41(3-4):181-91. doi: 10.1159/000444704. Epub 2016 Apr 6.

PMID:
27045590
47.

Dogs with Cognitive Dysfunction as a Spontaneous Model for Early Alzheimer's Disease: A Translational Study of Neuropathological and Inflammatory Markers.

Schütt T, Helboe L, Pedersen LØ, Waldemar G, Berendt M, Pedersen JT.

J Alzheimers Dis. 2016 Mar 15;52(2):433-49. doi: 10.3233/JAD-151085.

PMID:
27003213
48.

Defeating Alzheimer's disease and other dementias: a priority for European science and society.

Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H, Cedazo-Minguez A, Dubois B, Edvardsson D, Feldman H, Fratiglioni L, Frisoni GB, Gauthier S, Georges J, Graff C, Iqbal K, Jessen F, Johansson G, Jönsson L, Kivipelto M, Knapp M, Mangialasche F, Melis R, Nordberg A, Rikkert MO, Qiu C, Sakmar TP, Scheltens P, Schneider LS, Sperling R, Tjernberg LO, Waldemar G, Wimo A, Zetterberg H.

Lancet Neurol. 2016 Apr;15(5):455-532. doi: 10.1016/S1474-4422(16)00062-4. Review. No abstract available.

PMID:
26987701
49.

Contact Heat Evoked Potentials (CHEPs) in Patients with Mild-Moderate Alzheimer's Disease and Matched Control--A Pilot Study.

Jensen-Dahm C, Madsen CS, Waldemar G, Ballegaard M, Hejl AM, Johnsen B, Jensen TS.

Pain Med. 2016 Apr;17(4):675-84. doi: 10.1093/pm/pnv012. Epub 2015 Dec 14.

PMID:
26814248
50.

Effects of literacy on semantic verbal fluency in an immigrant population.

Nielsen TR, Waldemar G.

Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2016 Sep;23(5):578-90. doi: 10.1080/13825585.2015.1132668. Epub 2016 Jan 20.

PMID:
26786839
51.

Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer's Disease: A Randomized Controlled Trial.

Hoffmann K, Sobol NA, Frederiksen KS, Beyer N, Vogel A, Vestergaard K, Brændgaard H, Gottrup H, Lolk A, Wermuth L, Jacobsen S, Laugesen LP, Gergelyffy RG, Høgh P, Bjerregaard E, Andersen BB, Siersma V, Johannsen P, Cotman CW, Waldemar G, Hasselbalch SG.

J Alzheimers Dis. 2016;50(2):443-53. doi: 10.3233/JAD-150817.

PMID:
26682695
52.

Alcohol consumption and mortality in patients with mild Alzheimer's disease: a prospective cohort study.

Berntsen S, Kragstrup J, Siersma V, Waldemar G, Waldorff FB.

BMJ Open. 2015 Dec 11;5(12):e007851. doi: 10.1136/bmjopen-2015-007851.

53.

Quantitative Electroencephalography as a Diagnostic Tool for Alzheimer's Dementia in Adults with Down Syndrome.

Salem LC, Sabers A, Kjaer TW, Musaeus C, Nielsen MN, Nielsen AG, Waldemar G.

Dement Geriatr Cogn Dis Extra. 2015 Oct 21;5(3):404-13. doi: 10.1159/000438857. eCollection 2015 Sep-Dec.

54.

Combining the Rowland Universal Dementia Assessment Scale and the Informant Questionnaire on Cognitive Decline in the Elderly to Improve Detection of Dementia in an Arabic-Speaking Population.

Nielsen TR, Phung TK, Chaaya M, Mackinnon A, Waldemar G.

Dement Geriatr Cogn Disord. 2016;41(1-2):46-54. doi: 10.1159/000441649. Epub 2015 Nov 28.

55.

Defective mitochondrial respiration, altered dNTP pools and reduced AP endonuclease 1 activity in peripheral blood mononuclear cells of Alzheimer's disease patients.

Maynard S, Hejl AM, Dinh TS, Keijzers G, Hansen ÅM, Desler C, Moreno-Villanueva M, Bürkle A, Rasmussen LJ, Waldemar G, Bohr VA.

Aging (Albany NY). 2015 Oct;7(10):793-815.

56.

Time trends in antipsychotic drug use in patients with dementia: a nationwide study.

Nørgaard A, Jensen-Dahm C, Gasse C, Hansen HV, Waldemar G.

J Alzheimers Dis. 2016;49(1):211-20. doi: 10.3233/JAD-150481.

PMID:
26444790
57.
58.

Autonomic Dysfunction in Patients with Mild to Moderate Alzheimer's Disease.

Jensen-Dahm C, Waldemar G, Staehelin Jensen T, Malmqvist L, Moeller MM, Andersen BB, Høgh P, Ballegaard M.

J Alzheimers Dis. 2015;47(3):681-9. doi: 10.3233/JAD-150169.

PMID:
26401703
59.

Biochemical Markers of Physical Exercise on Mild Cognitive Impairment and Dementia: Systematic Review and Perspectives.

Jensen CS, Hasselbalch SG, Waldemar G, Simonsen AH.

Front Neurol. 2015 Aug 26;6:187. doi: 10.3389/fneur.2015.00187. eCollection 2015. Review.

60.

Performance of the 16-Item Informant Questionnaire on Cognitive Decline for the Elderly (IQCODE) in an Arabic-Speaking Older Population.

Phung TK, Chaaya M, Asmar K, Atweh S, Ghusn H, Khoury RM, Prince M, Waldemar G.

Dement Geriatr Cogn Disord. 2015;40(5-6):276-89. doi: 10.1159/000437092. Epub 2015 Aug 25.

61.

[Biomarkers for early diagnosis of Alzheimer's disease].

Frederiksen KS, Hasselbalch S, Law I, Højgaard L, Waldemar G.

Ugeskr Laeger. 2015 Jun 8;177(24). pii: V12140684. Review. Danish.

PMID:
26058526
62.

Knowledge and perceptions of dementia and Alzheimer's disease in four ethnic groups in Copenhagen, Denmark.

Nielsen TR, Waldemar G.

Int J Geriatr Psychiatry. 2016 Mar;31(3):222-30. doi: 10.1002/gps.4314. Epub 2015 Jun 4.

PMID:
26040575
63.

Cerebrospinal Fluid Biomarkers in Familial Forms of Alzheimer's Disease and Frontotemporal Dementia.

Rostgaard N, Waldemar G, Nielsen JE, Simonsen AH.

Dement Geriatr Cogn Disord. 2015;40(1-2):54-62. doi: 10.1159/000381828. Epub 2015 May 13. Review.

64.

Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.

Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FR, Visser PJ; Amyloid Biomarker Study Group, Aalten P, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, Barthel H, van Berckel BN, Bibeau K, Blennow K, Brooks DJ, van Buchem MA, Camus V, Cavedo E, Chen K, Chetelat G, Cohen AD, Drzezga A, Engelborghs S, Fagan AM, Fladby T, Fleisher AS, van der Flier WM, Ford L, Förster S, Fortea J, Foskett N, Frederiksen KS, Freund-Levi Y, Frisoni GB, Froelich L, Gabryelewicz T, Gill KD, Gkatzima O, Gómez-Tortosa E, Gordon MF, Grimmer T, Hampel H, Hausner L, Hellwig S, Herukka SK, Hildebrandt H, Ishihara L, Ivanoiu A, Jagust WJ, Johannsen P, Kandimalla R, Kapaki E, Klimkowicz-Mrowiec A, Klunk WE, Köhler S, Koglin N, Kornhuber J, Kramberger MG, Van Laere K, Landau SM, Lee DY, de Leon M, Lisetti V, Lleó A, Madsen K, Maier W, Marcusson J, Mattsson N, de Mendonça A, Meulenbroek O, Meyer PT, Mintun MA, Mok V, Molinuevo JL, Møllergård HM, Morris JC, Mroczko B, Van der Mussele S, Na DL, Newberg A, Nordberg A, Nordlund A, Novak GP, Paraskevas GP, Parnetti L, Perera G, Peters O, Popp J, Prabhakar S, Rabinovici GD, Ramakers IH, Rami L, Resende de Oliveira C, Rinne JO, Rodrigue KM, Rodríguez-Rodríguez E, Roe CM, Rot U, Rowe CC, Rüther E, Sabri O, Sanchez-Juan P, Santana I, Sarazin M, Schröder J, Schütte C, Seo SW, Soetewey F, Soininen H, Spiru L, Struyfs H, Teunissen CE, Tsolaki M, Vandenberghe R, Verbeek MM, Villemagne VL, Vos SJ, van Waalwijk van Doorn LJ, Waldemar G, Wallin A, Wallin ÅK, Wiltfang J, Wolk DA, Zboch M, Zetterberg H.

JAMA. 2015 May 19;313(19):1924-38. doi: 10.1001/jama.2015.4668.

65.

Validation of the Arabic Rowland Universal Dementia Assessment Scale (A-RUDAS) in elderly with mild and moderate dementia.

Chaaya M, Phung TK, El Asmar K, Atweh S, Ghusn H, Khoury RM, Prince M, Nielsen TR, Waldemar G.

Aging Ment Health. 2016 Aug;20(8):880-7. doi: 10.1080/13607863.2015.1043620. Epub 2015 May 18.

PMID:
25984584
66.

Subjective cognitive complaints included in diagnostic evaluation of dementia helps accurate diagnosis in a mixed memory clinic cohort.

Salem LC, Vogel A, Ebstrup J, Linneberg A, Waldemar G.

Int J Geriatr Psychiatry. 2015 Dec;30(12):1177-85. doi: 10.1002/gps.4272. Epub 2015 Apr 17.

PMID:
25892198
67.

Discrepancy between stimulus response and tolerance of pain in Alzheimer disease.

Jensen-Dahm C, Werner MU, Jensen TS, Ballegaard M, Andersen BB, Høgh P, Waldemar G.

Neurology. 2015 Apr 14;84(15):1575-81. doi: 10.1212/WNL.0000000000001465. Epub 2015 Mar 18.

68.

[The prevalence of dementia in Denmark].

Jørgensen K, Waldemar G.

Ugeskr Laeger. 2014 Nov 24;176(48). pii: V06140325. Review. Danish.

PMID:
25430573
69.

Physical activity in the elderly is associated with improved executive function and processing speed: the LADIS Study.

Frederiksen KS, Verdelho A, Madureira S, Bäzner H, O'Brien JT, Fazekas F, Scheltens P, Schmidt R, Wallin A, Wahlund LO, Erkinjunttii T, Poggesi A, Pantoni L, Inzitari D, Waldemar G; LADIS Study.

Int J Geriatr Psychiatry. 2015 Jul;30(7):744-50. doi: 10.1002/gps.4220. Epub 2014 Nov 3.

PMID:
25363336
70.

The EADC-ADNI Harmonized Protocol for manual hippocampal segmentation on magnetic resonance: evidence of validity.

Frisoni GB, Jack CR Jr, Bocchetta M, Bauer C, Frederiksen KS, Liu Y, Preboske G, Swihart T, Blair M, Cavedo E, Grothe MJ, Lanfredi M, Martinez O, Nishikawa M, Portegies M, Stoub T, Ward C, Apostolova LG, Ganzola R, Wolf D, Barkhof F, Bartzokis G, DeCarli C, Csernansky JG, deToledo-Morrell L, Geerlings MI, Kaye J, Killiany RJ, Lehéricy S, Matsuda H, O'Brien J, Silbert LC, Scheltens P, Soininen H, Teipel S, Waldemar G, Fellgiebel A, Barnes J, Firbank M, Gerritsen L, Henneman W, Malykhin N, Pruessner JC, Wang L, Watson C, Wolf H, deLeon M, Pantel J, Ferrari C, Bosco P, Pasqualetti P, Duchesne S, Duvernoy H, Boccardi M; EADC-ADNI Working Group on The Harmonized Protocol for Manual Hippocampal Volumetry and for the Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2015 Feb;11(2):111-25. doi: 10.1016/j.jalz.2014.05.1756. Epub 2014 Sep 27.

71.

Frequent use of opioids in patients with dementia and nursing home residents: A study of the entire elderly population of Denmark.

Jensen-Dahm C, Gasse C, Astrup A, Mortensen PB, Waldemar G.

Alzheimers Dement. 2015 Jun;11(6):691-9. doi: 10.1016/j.jalz.2014.06.013. Epub 2014 Sep 16.

72.

World Federation of Societies of Biological Psychiatry guidelines for the pharmacological treatment of dementias in primary care.

Ihl R, Bunevicius R, Frölich L, Winblad B, Schneider LS, Dubois B, Burns A, Thibaut F, Kasper S, Möller HJ; WFSBP Task Force on Mental Disorders in Primary Care; WFSBP Task Force on Dementia.

Int J Psychiatry Clin Pract. 2015 Mar;19(1):2-7. doi: 10.3109/13651501.2014.961931. Epub 2014 Oct 18. Review.

PMID:
25195764
73.

Polish Code of Ethics of a Medical Laboratory Specialist.

Elżbieta P, Waldemar G, Barbara MC.

EJIFCC. 2014 Sep 4;25(2):199-206. eCollection 2014 Sep.

74.

Longitudinal changes in awareness over 36 months in patients with mild Alzheimer's disease.

Vogel A, Waldorff FB, Waldemar G.

Int Psychogeriatr. 2015 Jan;27(1):95-102. doi: 10.1017/S1041610214001562. Epub 2014 Jul 30.

PMID:
25075811
75.

The six-item Clock Drawing Test - reliability and validity in mild Alzheimer's disease.

Jørgensen K, Kristensen MK, Waldemar G, Vogel A.

Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2015;22(3):301-11. doi: 10.1080/13825585.2014.932325. Epub 2014 Jun 30.

PMID:
24974730
76.

Validation of the 10/66 Dementia Research Group diagnostic assessment for dementia in Arabic: a study in Lebanon.

Phung KT, Chaaya M, Waldemar G, Atweh S, Asmar K, Ghusn H, Karam G, Sawaya R, Khoury RM, Zeinaty I, Salman S, Hammoud S, Radwan W, Bassil N, Prince M.

J Geriatr Psychiatry Neurol. 2014 Dec;27(4):282-90. doi: 10.1177/0891988714532019. Epub 2014 Apr 25.

77.

Moderate-to-high intensity aerobic exercise in patients with mild to moderate Alzheimer's disease: a pilot study.

Frederiksen KS, Sobol N, Beyer N, Hasselbalch S, Waldemar G.

Int J Geriatr Psychiatry. 2014 Dec;29(12):1242-8. doi: 10.1002/gps.4096. Epub 2014 Apr 15.

PMID:
24733599
78.

Neurological abnormalities predict disability: the LADIS (Leukoaraiosis And DISability) study.

Poggesi A, Gouw A, van der Flier W, Pracucci G, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Blahak C, Langhorne P, O'Brien J, Schmidt R, Visser MC, Wahlund LO, Waldemar G, Wallin A, Scheltens P, Inzitari D, Pantoni L.

J Neurol. 2014 Jun;261(6):1160-9. doi: 10.1007/s00415-014-7332-9. Epub 2014 Apr 11.

PMID:
24723116
79.

Inadequate diagnostic evaluation in young patients registered with a diagnosis of dementia: a nationwide register-based study.

Salem LC, Andersen BB, Nielsen TR, Stokholm J, Jørgensen MB, Waldemar G.

Dement Geriatr Cogn Dis Extra. 2014 Feb 1;4(1):31-44. doi: 10.1159/000358050. eCollection 2014 Jan.

80.

The potential of microRNAs as biofluid markers of neurodegenerative diseases--a systematic review.

Danborg PB, Simonsen AH, Waldemar G, Heegaard NH.

Biomarkers. 2014 Jun;19(4):259-68. doi: 10.3109/1354750X.2014.904001. Epub 2014 Mar 29. Review.

PMID:
24678935
81.

Harmonized diagnostic criteria for Alzheimer's disease: recommendations.

Morris JC, Blennow K, Froelich L, Nordberg A, Soininen H, Waldemar G, Wahlund LO, Dubois B.

J Intern Med. 2014 Mar;275(3):204-13. doi: 10.1111/joim.12199.

82.

Early psychosocial intervention in Alzheimer's disease: cost utility evaluation alongside the Danish Alzheimer's Intervention Study (DAISY).

Søgaard R, Sørensen J, Waldorff FB, Eckermann A, Buss DV, Phung KT, Waldemar G; DAISY Study Investigators.

BMJ Open. 2014 Jan 15;4(1):e004105. doi: 10.1136/bmjopen-2013-004105.

83.

The PredictAD project: development of novel biomarkers and analysis software for early diagnosis of the Alzheimer's disease.

Antila K, Lötjönen J, Thurfjell L, Laine J, Massimini M, Rueckert D, Zubarev RA, Orešič M, van Gils M, Mattila J, Hviid Simonsen A, Waldemar G, Soininen H.

Interface Focus. 2013 Apr 6;3(2):20120072. doi: 10.1098/rsfs.2012.0072.

84.

Quantitative sensory testing and pain tolerance in patients with mild to moderate Alzheimer disease compared to healthy control subjects.

Jensen-Dahm C, Werner MU, Dahl JB, Jensen TS, Ballegaard M, Hejl AM, Waldemar G.

Pain. 2014 Aug;155(8):1439-45. doi: 10.1016/j.pain.2013.12.031. Epub 2014 Jan 8.

PMID:
24412285
85.

A 2-year prospective cohort study of antidementia drug non-persistency in mild-to-moderate Alzheimer's disease in Europe : predictors of discontinuation and switch in the ICTUS study.

Gardette V, Lapeyre-Mestre M, Piau A, Gallini A, Cantet C, Montastruc JL, Vellas B, Andrieu S; ICTUS Group.

CNS Drugs. 2014 Feb;28(2):157-70. doi: 10.1007/s40263-013-0133-3.

PMID:
24408842
86.

A three-year follow-up on the efficacy of psychosocial interventions for patients with mild dementia and their caregivers: the multicentre, rater-blinded, randomised Danish Alzheimer Intervention Study (DAISY).

Phung KT, Waldorff FB, Buss DV, Eckermann A, Keiding N, Rishøj S, Siersma V, Sørensen J, Søgaard R, Sørensen LV, Vogel A, Waldemar G.

BMJ Open. 2013 Nov 21;3(11):e003584. doi: 10.1136/bmjopen-2013-003584.

87.

Application of the PredictAD decision support tool to a Danish cohort of patients with Alzheimer's disease and other dementias.

Simonsen AH, Mattila J, Hejl AM, Garde E, van Gils M, Thomsen C, Lötjönen J, Soininen H, Waldemar G.

Dement Geriatr Cogn Disord. 2014;37(3-4):207-13. doi: 10.1159/000354372. Epub 2013 Oct 26.

PMID:
24193095
88.

Cost analysis of early psychosocial intervention in Alzheimer's disease.

Søgaard R, Sørensen J, Waldorff FB, Eckermann A, Buss DV, Waldemar G.

Dement Geriatr Cogn Disord. 2014;37(3-4):141-53. doi: 10.1159/000355368. Epub 2013 Oct 19.

PMID:
24157706
89.

Preserving cognition, quality of life, physical health and functional ability in Alzheimer's disease: the effect of physical exercise (ADEX trial): rationale and design.

Hoffmann K, Frederiksen KS, Sobol NA, Beyer N, Vogel A, Simonsen AH, Johannsen P, Lolk A, Terkelsen O, Cotman CW, Hasselbalch SG, Waldemar G.

Neuroepidemiology. 2013;41(3-4):198-207. doi: 10.1159/000354632. Epub 2013 Oct 15.

90.

Validation of the Rowland Universal Dementia Assessment Scale for multicultural screening in Danish memory clinics.

Nielsen TR, Andersen BB, Gottrup H, Lützhøft JH, Høgh P, Waldemar G.

Dement Geriatr Cogn Disord. 2013;36(5-6):354-62. doi: 10.1159/000354375. Epub 2013 Sep 10.

PMID:
24022429
91.

The predictive value of self-rated health in the presence of subjective memory complaints on permanent nursing home placement in elderly primary care patients over 4-year follow-up.

Nielsen AB, Siersma V, Waldemar G, Waldorff FB.

Age Ageing. 2014 Jan;43(1):50-7. doi: 10.1093/ageing/aft131. Epub 2013 Aug 28.

PMID:
23985335
92.

Shape abnormalities of the caudate nucleus correlate with poorer gait and balance: results from a subset of the LADIS study.

Macfarlane MD, Looi JC, Walterfang M, Spulber G, Velakoulis D, Styner M, Crisby M, Orndahl E, Erkinjuntti T, Waldemar G, Garde E, Hennerici MG, Bäzner H, Blahak C, Wallin A, Wahlund LO; LADIS Study Group.

Am J Geriatr Psychiatry. 2015 Jan;23(1):59-71.e1. doi: 10.1016/j.jagp.2013.04.011. Epub 2013 Aug 1.

93.

Executive dysfunction correlates with caudate nucleus atrophy in patients with white matter changes on MRI: a subset of LADIS.

Macfarlane MD, Looi JC, Walterfang M, Spulber G, Velakoulis D, Crisby M, Orndahl E, Erkinjuntti T, Garde E, Waldemar G, Wallin A, Wahlund LO; LADIS Study Group.

Psychiatry Res. 2013 Oct 30;214(1):16-23. doi: 10.1016/j.pscychresns.2013.05.010. Epub 2013 Aug 2.

PMID:
23916538
94.

Deterioration of gait and balance over time: the effects of age-related white matter change--the LADIS study.

Kreisel SH, Blahak C, Bäzner H, Inzitari D, Pantoni L, Poggesi A, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Langhorne P, O'Brien J, Scheltens P, Visser MC, Wahlund LO, Waldemar G, Wallin A, Hennerici MG.

Cerebrovasc Dis. 2013;35(6):544-53. doi: 10.1159/000350725. Epub 2013 Jul 6.

PMID:
23838682
95.

Depressive symptoms predict cognitive decline and dementia in older people independently of cerebral white matter changes: the LADIS study.

Verdelho A, Madureira S, Moleiro C, Ferro JM, O'Brien JT, Poggesi A, Pantoni L, Fazekas F, Scheltens P, Waldemar G, Wallin A, Erkinjuntti T, Inzitari D; LADIS Study.

J Neurol Neurosurg Psychiatry. 2013 Nov;84(11):1250-4. doi: 10.1136/jnnp-2012-304191. Epub 2013 May 28.

PMID:
23715914
96.

Pre-analytical factors influencing the stability of cerebrospinal fluid proteins.

Simonsen AH, Bahl JM, Danborg PB, Lindstrom V, Larsen SO, Grubb A, Heegaard NH, Waldemar G.

J Neurosci Methods. 2013 May 15;215(2):234-40. doi: 10.1016/j.jneumeth.2013.03.011. Epub 2013 Mar 26.

PMID:
23537933
97.

Predicting AD conversion: comparison between prodromal AD guidelines and computer assisted PredictAD tool.

Liu Y, Mattila J, Ruiz MÁ, Paajanen T, Koikkalainen J, van Gils M, Herukka SK, Waldemar G, Lötjönen J, Soininen H; Alzheimer's Disease Neuroimaging Initiative.

PLoS One. 2013;8(2):e55246. doi: 10.1371/journal.pone.0055246. Epub 2013 Feb 12.

98.

Confirmatory factor analysis of the Neuropsychological Assessment Battery of the LADIS study: a longitudinal analysis.

Moleiro C, Madureira S, Verdelho A, Ferro JM, Poggesi A, Chabriat H, Erkinjuntti T, Fazekas F, Hennerici M, O'Brien J, Pantoni L, Salvadori E, Scheltens P, Visser MC, Wahlund LO, Waldemar G, Wallin A, Inzitari D; LADIS Study.

J Clin Exp Neuropsychol. 2013;35(3):269-78. doi: 10.1080/13803395.2013.770822. Epub 2013 Feb 11.

PMID:
23398381
99.

Added Diagnostic Value of (11)C-PiB-PET in Memory Clinic Patients with Uncertain Diagnosis.

Frederiksen KS, Hasselbalch SG, Hejl AM, Law I, Højgaard L, Waldemar G.

Dement Geriatr Cogn Dis Extra. 2012 Jan;2(1):610-21. doi: 10.1159/000345783. Epub 2012 Dec 13.

100.

Subjective memory complaints in primary care patients and death from all causes: a four-year follow-up.

Siersma V, Waldemar G, Waldorff FB.

Scand J Prim Health Care. 2013 Mar;31(1):7-12. doi: 10.3109/02813432.2012.754092. Epub 2013 Jan 17.

101.

[Efficacy of cognitive stimulation therapy in patients with dementia].

Øksnebjerg L, Waldemar G.

Ugeskr Laeger. 2012 Dec 10;174(50):3161-4. Danish.

PMID:
23286767
102.

Application of the PredictAD software tool to predict progression in patients with mild cognitive impairment.

Simonsen AH, Mattila J, Hejl AM, Frederiksen KS, Herukka SK, Hallikainen M, van Gils M, Lötjönen J, Soininen H, Waldemar G.

Dement Geriatr Cogn Disord. 2012;34(5-6):344-50. doi: 10.1159/000345554. Epub 2012 Dec 6.

103.

Overdiagnosis of dementia in young patients - a nationwide register-based study.

Salem LC, Andersen BB, Nielsen TR, Stokholm J, Jørgensen MB, Rasmussen MH, Waldemar G.

Dement Geriatr Cogn Disord. 2012;34(5-6):292-9. doi: 10.1159/000345485. Epub 2012 Nov 30.

PMID:
23208125
104.

Cerebral white matter changes are associated with abnormalities on neurological examination in non-disabled elderly: the LADIS study.

Poggesi A, Gouw A, van der Flier W, Pracucci G, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Hennerici M, Langhorne P, O'Brien JT, Visser MC, Wahlund LO, Waldemar G, Wallin A, Scheltens P, Inzitari D, Pantoni L.

J Neurol. 2013 Apr;260(4):1014-21. doi: 10.1007/s00415-012-6748-3. Epub 2012 Nov 20.

PMID:
23180181
105.

Cognitive testing in non-demented Turkish immigrants--comparison of the RUDAS and the MMSE.

Nielsen TR, Vogel A, Gade A, Waldemar G.

Scand J Psychol. 2012 Dec;53(6):455-60. doi: 10.1111/sjop.12018.

PMID:
23170863
106.

Visual processing speed in old age.

Habekost T, Vogel A, Rostrup E, Bundesen C, Kyllingsbaek S, Garde E, Ryberg C, Waldemar G.

Scand J Psychol. 2013 Apr;54(2):89-94. doi: 10.1111/sjop.12008. Epub 2012 Nov 2.

PMID:
23121639
107.

Physical activity prevents progression for cognitive impairment and vascular dementia: results from the LADIS (Leukoaraiosis and Disability) study.

Verdelho A, Madureira S, Ferro JM, Baezner H, Blahak C, Poggesi A, Hennerici M, Pantoni L, Fazekas F, Scheltens P, Waldemar G, Wallin A, Erkinjuntti T, Inzitari D; LADIS Study.

Stroke. 2012 Dec;43(12):3331-5. doi: 10.1161/STROKEAHA.112.661793. Epub 2012 Nov 1.

PMID:
23117721
108.

Optimizing the diagnosis of early Alzheimer's disease in mild cognitive impairment subjects.

Mattila J, Soininen H, Koikkalainen J, Rueckert D, Wolz R, Waldemar G, Lötjönen J.

J Alzheimers Dis. 2012;32(4):969-79. doi: 10.3233/JAD-2012-120934.

PMID:
22890102
109.

White matter lesion progression in LADIS: frequency, clinical effects, and sample size calculations.

Schmidt R, Berghold A, Jokinen H, Gouw AA, van der Flier WM, Barkhof F, Scheltens P, Petrovic K, Madureira S, Verdelho A, Ferro JM, Waldemar G, Wallin A, Wahlund LO, Poggesi A, Pantoni L, Inzitari D, Fazekas F, Erkinjuntti T; LADIS Study Group.

Stroke. 2012 Oct;43(10):2643-7. Epub 2012 Aug 9.

PMID:
22879094
110.

Efficacy of psychosocial intervention in patients with mild Alzheimer's disease: the multicentre, rater blinded, randomised Danish Alzheimer Intervention Study (DAISY).

Waldorff FB, Buss DV, Eckermann A, Rasmussen ML, Keiding N, Rishøj S, Siersma V, Sørensen J, Sørensen LV, Vogel A, Waldemar G.

BMJ. 2012 Jul 17;345:e4693. doi: 10.1136/bmj.e4693.

111.

Comparison of performance on three neuropsychological tests in healthy Turkish immigrants and Danish elderly.

Nielsen TR, Vogel A, Waldemar G.

Int Psychogeriatr. 2012 Sep;24(9):1515-21. doi: 10.1017/S1041610212000440. Epub 2012 Apr 16.

PMID:
22717281
112.

Discrepancy between self- and proxy-rated pain in Alzheimer's disease: results from the Danish Alzheimer Intervention Study.

Jensen-Dahm C, Vogel A, Waldorff FB, Waldemar G.

J Am Geriatr Soc. 2012 Jul;60(7):1274-8. doi: 10.1111/j.1532-5415.2012.04036.x. Epub 2012 Jun 15.

PMID:
22702408
113.

Protein markers for the differential diagnosis of vascular dementia and Alzheimer's disease.

Simonsen AH, Hagnelius NO, Waldemar G, Nilsson TK, McGuire J.

Int J Proteomics. 2012;2012:824024. doi: 10.1155/2012/824024. Epub 2012 Jun 4.

114.

Relationship between progression of brain white matter changes and late-life depression: 3-year results from the LADIS study.

Firbank MJ, Teodorczuk A, van der Flier WM, Gouw AA, Wallin A, Erkinjuntti T, Inzitari D, Wahlund LO, Pantoni L, Poggesi A, Pracucci G, Langhorne P, O'Brien JT; LADIS group.

Br J Psychiatry. 2012 Jul;201(1):40-5. doi: 10.1192/bjp.bp.111.098897. Epub 2012 May 24.

PMID:
22626634
115.

Indicators for root caries in Danish persons with recently diagnosed Alzheimer's disease.

Ellefsen BS, Morse DE, Waldemar G, Holm-Pedersen P.

Gerodontology. 2012 Sep;29(3):194-202. doi: 10.1111/j.1741-2358.2011.00560.x. Epub 2012 Apr 30.

PMID:
22540768
116.

Callosal tissue loss parallels subtle decline in psychomotor speed. a longitudinal quantitative MRI study. The LADIS Study.

Jokinen H, Frederiksen KS, Garde E, Skimminge A, Siebner H, Waldemar G, Ylikoski R, Madureira S, Verdelho A, van Straaten EC, Barkhof F, Fazekas F, Schmidt R, Pantoni L, Inzitari D, Erkinjuntti T.

Neuropsychologia. 2012 Jun;50(7):1650-5. doi: 10.1016/j.neuropsychologia.2012.03.020. Epub 2012 Apr 2.

PMID:
22497753
117.

The spatial distribution of age-related white matter changes as a function of vascular risk factors--results from the LADIS study.

Rostrup E, Gouw AA, Vrenken H, van Straaten EC, Ropele S, Pantoni L, Inzitari D, Barkhof F, Waldemar G; LADIS study group.

Neuroimage. 2012 Apr 15;60(3):1597-607. doi: 10.1016/j.neuroimage.2012.01.106. Epub 2012 Jan 28.

PMID:
22305990
118.

Combination of biomarkers: PET [18F]flutemetamol imaging and structural MRI in dementia and mild cognitive impairment.

Thurfjell L, Lötjönen J, Lundqvist R, Koikkalainen J, Soininen H, Waldemar G, Brooks DJ, Vandenberghe R.

Neurodegener Dis. 2012;10(1-4):246-9. doi: 10.1159/000335381. Epub 2012 Feb 1.

PMID:
22301718
120.

2001-2011: A Decade of the LADIS (Leukoaraiosis And DISability) Study: What Have We Learned about White Matter Changes and Small-Vessel Disease?

The LADIS Study Group, Poggesi A, Pantoni L, Inzitari D, Fazekas F, Ferro J, O'Brien J, Hennerici M, Scheltens P, Erkinjuntti T, Visser M, Langhorne P, Chabriat H, Waldemar G, Wallin A, Wahlund A.

Cerebrovasc Dis. 2011;32(6):577-588. Epub 2011 Dec 1.

121.

Corpus callosum tissue loss and development of motor and global cognitive impairment: the LADIS study.

Frederiksen KS, Garde E, Skimminge A, Barkhof F, Scheltens P, van Straaten EC, Fazekas F, Baezner H, Verdelho A, Ferro JM, Erkinjuntti T, Jokinen H, Wahlund LO, O'Brien JT, Basile AM, Pantoni L, Inzitari D, Waldemar G.

Dement Geriatr Cogn Disord. 2011;32(4):279-86. doi: 10.1159/000334949. Epub 2012 Jan 19.

122.

Subjective memory complaints in general practice predicts future dementia: a 4-year follow-up study.

Waldorff FB, Siersma V, Vogel A, Waldemar G.

Int J Geriatr Psychiatry. 2012 Nov;27(11):1180-8. doi: 10.1002/gps.3765. Epub 2012 Jan 17.

PMID:
22253004
123.

Software tool for improved prediction of Alzheimer's disease.

Soininen H, Mattila J, Koikkalainen J, van Gils M, Hviid Simonsen A, Waldemar G, Rueckert D, Thurfjell L, Lötjönen J; Alzheimer’s Disease Neuroimaging Initiative.

Neurodegener Dis. 2012;10(1-4):149-52. doi: 10.1159/000332600. Epub 2011 Dec 9.

124.

White matter hyperintensities and prepulse inhibition in a mixed elderly population.

Salem LC, Hejl AM, Garde E, Leffers AM, Paulson OB, Waldemar G.

Psychiatry Res. 2011 Dec 30;194(3):314-318. doi: 10.1016/j.pscychresns.2011.07.007. Epub 2011 Oct 30.

PMID:
22041531
125.

Collaborative research between academia and industry using a large clinical trial database: a case study in Alzheimer's disease.

Jones R, Wilkinson D, Lopez OL, Cummings J, Waldemar G, Zhang R, Mackell J, Gauthier S.

Trials. 2011 Oct 26;12:233. doi: 10.1186/1745-6215-12-233.

126.

Validity, reliability, and feasibility of clinical staging scales in dementia: a systematic review.

Rikkert MG, Tona KD, Janssen L, Burns A, Lobo A, Robert P, Sartorius N, Stoppe G, Waldemar G.

Am J Alzheimers Dis Other Demen. 2011 Aug;26(5):357-65. doi: 10.1177/1533317511418954. Epub 2011 Sep 13. Review.

PMID:
21914671
127.

Self-perceived memory complaints predict progression to Alzheimer disease. The LADIS study.

Verdelho A, Madureira S, Moleiro C, Santos CO, Ferro JM, Erkinjuntti T, Poggesi A, Pantoni L, Fazekas F, Scheltens P, Waldemar G, Wallin A, Inzitari D; LADIS Study.

J Alzheimers Dis. 2011;27(3):491-8. doi: 10.3233/JAD-2011-110494.

PMID:
21841255
128.

A disease state fingerprint for evaluation of Alzheimer's disease.

Mattila J, Koikkalainen J, Virkki A, Simonsen A, van Gils M, Waldemar G, Soininen H, Lötjönen J; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2011;27(1):163-76. doi: 10.3233/JAD-2011-110365.

PMID:
21799247
129.

Proxy-rated quality of life in Alzheimer's disease: a three-year longitudinal study.

Vogel A, Bhattacharya S, Waldorff FB, Waldemar G.

Int Psychogeriatr. 2012 Jan;24(1):82-9. doi: 10.1017/S1041610211001128. Epub 2011 Jun 28.

PMID:
21729415
130.

Quality of dementia diagnostic evaluation for ethnic minority patients: a nationwide study.

Nielsen TR, Andersen BB, Kastrup M, Phung TK, Waldemar G.

Dement Geriatr Cogn Disord. 2011;31(5):388-96. doi: 10.1159/000327362. Epub 2011 Jul 1.

PMID:
21720163
131.

Corpus callosum atrophy in patients with mild Alzheimer's disease.

Frederiksen KS, Garde E, Skimminge A, Ryberg C, Rostrup E, Baaré WF, Siebner HR, Hejl AM, Leffers AM, Waldemar G.

Neurodegener Dis. 2011;8(6):476-82. doi: 10.1159/000327753. Epub 2011 Jun 9.

PMID:
21659724
132.

Corpus callosum atrophy as a predictor of age-related cognitive and motor impairment: a 3-year follow-up of the LADIS study cohort.

Ryberg C, Rostrup E, Paulson OB, Barkhof F, Scheltens P, van Straaten EC, van der Flier WM, Fazekas F, Schmidt R, Ferro JM, Baezner H, Erkinjuntti T, Jokinen H, Wahlund LO, Poggesi A, Pantoni L, Inzitari D, Waldemar G; LADIS study group.

J Neurol Sci. 2011 Aug 15;307(1-2):100-5. doi: 10.1016/j.jns.2011.05.002. Epub 2011 May 31.

PMID:
21621224
133.

Incident lacunes influence cognitive decline: the LADIS study.

Jokinen H, Gouw AA, Madureira S, Ylikoski R, van Straaten EC, van der Flier WM, Barkhof F, Scheltens P, Fazekas F, Schmidt R, Verdelho A, Ferro JM, Pantoni L, Inzitari D, Erkinjuntti T; LADIS Study Group.

Neurology. 2011 May 31;76(22):1872-8. doi: 10.1212/WNL.0b013e31821d752f. Epub 2011 May 4.

PMID:
21543730
134.

Multi-template tensor-based morphometry: application to analysis of Alzheimer's disease.

Koikkalainen J, Lötjönen J, Thurfjell L, Rueckert D, Waldemar G, Soininen H; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2011 Jun 1;56(3):1134-44. doi: 10.1016/j.neuroimage.2011.03.029. Epub 2011 Mar 16.

135.

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of Alzheimer's disease and other dementias.

Ihl R, Frölich L, Winblad B, Schneider L, Burns A, Möller HJ; WFSBP Task Force on Treatment Guidelines for Alzheimer's Disease and other Dementias.

World J Biol Psychiatry. 2011 Feb;12(1):2-32. doi: 10.3109/15622975.2010.538083. Review.

PMID:
21288069
136.

Prognostic factors for weight loss over 1-year period in patients recently diagnosed with mild Alzheimer Disease.

Hansen ML, Waldorff FB, Waldemar G.

Alzheimer Dis Assoc Disord. 2011 Jul-Sep;25(3):269-75. doi: 10.1097/WAD.0b013e3182096624.

PMID:
21285857
137.

Fast and robust extraction of hippocampus from MR images for diagnostics of Alzheimer's disease.

Lötjönen J, Wolz R, Koikkalainen J, Julkunen V, Thurfjell L, Lundqvist R, Waldemar G, Soininen H, Rueckert D; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2011 May 1;56(1):185-96. doi: 10.1016/j.neuroimage.2011.01.062. Epub 2011 Jan 31.

138.

The Danish Alzheimer intervention study: rationale, study design and baseline characteristics of the cohort.

Waldemar G, Waldorff FB, Buss DV, Eckermann A, Keiding N, Rishøj S, Siersma V, Sørensen J, Sørensen LV, Vogel A.

Neuroepidemiology. 2011;36(1):52-61. doi: 10.1159/000322942. Epub 2010 Dec 22.

139.

Over- and under-diagnosis of dementia in ethnic minorities: a nationwide register-based study.

Nielsen TR, Vogel A, Phung TK, Gade A, Waldemar G.

Int J Geriatr Psychiatry. 2011 Nov;26(11):1128-35. doi: 10.1002/gps.2650. Epub 2010 Dec 30.

PMID:
21194100
140.

Predicting cognitive decline in Alzheimer's disease: an integrated analysis.

Lopez OL, Schwam E, Cummings J, Gauthier S, Jones R, Wilkinson D, Waldemar G, Zhang R, Schindler R.

Alzheimers Dement. 2010 Nov;6(6):431-9. doi: 10.1016/j.jalz.2010.04.003. Review.

PMID:
21044773
141.

Generic and disease-specific measures of quality of life in patients with mild Alzheimer's disease.

Bhattacharya S, Vogel A, Hansen ML, Waldorff FB, Waldemar G.

Dement Geriatr Cogn Disord. 2010;30(4):327-33. doi: 10.1159/000320588. Epub 2010 Oct 2.

PMID:
20924186
142.

Differences in resource use and costs of dementia care between European countries: baseline data from the ICTUS study.

Gustavsson A, Jonsson L, Rapp T, Reynish E, Ousset PJ, Andrieu S, Cantet C, Winblad B, Vellas B, Wimo A; ICTUS Study Group.

J Nutr Health Aging. 2010 Oct;14(8):648-54.

PMID:
20922341
143.

Hysterectomy, oophorectomy and risk of dementia: a nationwide historical cohort study.

Phung TK, Waltoft BL, Laursen TM, Settnes A, Kessing LV, Mortensen PB, Waldemar G.

Dement Geriatr Cogn Disord. 2010;30(1):43-50. doi: 10.1159/000314681. Epub 2010 Jul 30.

PMID:
20689282
144.

Effect of donepezil on cognition in severe Alzheimer's disease: a pooled data analysis.

Cummings J, Jones R, Wilkinson D, Lopez O, Gauthier S, Waldemar G, Zhang R, Xu Y, Sun Y, Richardson S, Mackell J.

J Alzheimers Dis. 2010;21(3):843-51. doi: 10.3233/JAD-2010-100078.

PMID:
20634594
145.

White matter changes and diabetes predict cognitive decline in the elderly: the LADIS study.

Verdelho A, Madureira S, Moleiro C, Ferro JM, Santos CO, Erkinjuntti T, Pantoni L, Fazekas F, Visser M, Waldemar G, Wallin A, Hennerici M, Inzitari D; LADIS Study.

Neurology. 2010 Jul 13;75(2):160-7. doi: 10.1212/WNL.0b013e3181e7ca05.

PMID:
20625169
146.

Assessment of dementia in ethnic minority patients in Europe: a European Alzheimer's Disease Consortium survey.

Nielsen TR, Vogel A, Riepe MW, de Mendonça A, Rodriguez G, Nobili F, Gade A, Waldemar G.

Int Psychogeriatr. 2011 Feb;23(1):86-95. doi: 10.1017/S1041610210000955. Epub 2010 Jul 6.

PMID:
20602861
147.

Proteomic investigations of the ventriculo-lumbar gradient in human CSF.

Simonsen AH, Bech S, Laursen I, Salvesen L, Winge K, Waldemar G, Werdelin L, Nielsen JE, McGuire JN, Hjermind LE.

J Neurosci Methods. 2010 Aug 30;191(2):244-8. doi: 10.1016/j.jneumeth.2010.06.017. Epub 2010 Jun 25.

PMID:
20599557
148.

Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease.

Waldemar G, Gauthier S, Jones R, Wilkinson D, Cummings J, Lopez O, Zhang R, Xu Y, Sun Y, Knox S, Richardson S, Mackell J.

Int J Geriatr Psychiatry. 2011 Feb;26(2):150-7. doi: 10.1002/gps.2507.

PMID:
20597141
149.

Effects of donepezil on activities of daily living: integrated analysis of patient data from studies in mild, moderate and severe Alzheimer's disease.

Gauthier S, Lopez OL, Waldemar G, Jones RW, Cummings J, Zhang R, Schindler R, Schwam E.

Int Psychogeriatr. 2010 Sep;22(6):973-83. doi: 10.1017/S1041610210000888. Epub 2010 Jun 10.

PMID:
20534179
150.

[Dementia in ethnic minorities].

Nielsen TR, Waldemar G.

Ugeskr Laeger. 2010 May 17;172(20):1527-31. Review. Danish.

PMID:
20483100
151.

Neuropsychological predictors of dementia in a three-year follow-up period: data from the LADIS study.

Madureira S, Verdelho A, Moleiro C, Ferro JM, Erkinjuntti T, Jokinen H, Pantoni L, Fazekas F, Van der Flier W, Visser M, Waldemar G, Wallin A, Hennerici M, Inzitari D.

Dement Geriatr Cogn Disord. 2010;29(4):325-34. doi: 10.1159/000278333. Epub 2010 Apr 14.

PMID:
20389074
152.

Diffusion-weighted imaging and cognition in the leukoariosis and disability in the elderly study.

Schmidt R, Ropele S, Ferro J, Madureira S, Verdelho A, Petrovic K, Gouw A, van der Flier WM, Enzinger C, Pantoni L, Inzitari D, Erkinjuntti T, Scheltens P, Wahlund LO, Waldemar G, Rostrup E, Wallin A, Barkhof F, Fazekas F; LADIS study group.

Stroke. 2010 May;41(5):e402-8. doi: 10.1161/STROKEAHA.109.576629. Epub 2010 Mar 4.

PMID:
20203319
153.

Impaired awareness of deficits and neuropsychiatric symptoms in early Alzheimer's disease: the Danish Alzheimer Intervention Study (DAISY).

Vogel A, Waldorff FB, Waldemar G.

J Neuropsychiatry Clin Neurosci. 2010 Winter;22(1):93-9. doi: 10.1176/appi.neuropsych.22.1.93.

PMID:
20160215
154.

Time trend in diagnosing dementia in secondary care.

Phung TK, Waltoft BL, Kessing LV, Mortensen PB, Waldemar G.

Dement Geriatr Cogn Disord. 2010;29(2):146-53. doi: 10.1159/000269933. Epub 2010 Feb 11.

PMID:
20150733
155.

Private costs almost equal health care costs when intervening in mild Alzheimer's: a cohort study alongside the DAISY trial.

Søgaard R, Sørensen J, Waldorff FB, Eckermann A, Buss DV, Waldemar G.

BMC Health Serv Res. 2009 Nov 25;9:215. doi: 10.1186/1472-6963-9-215.

156.

[Mobile phone use as a risk factor for affection of the central nerve system--secondary publication].

Schüz J, Waldemar G, Olsen JH, Johansen C.

Ugeskr Laeger. 2009 Nov 2;171(45):3268-71. Danish.

PMID:
19916195
157.

Assessing caries increments in elderly patients with and without dementia: a one-year follow-up study.

Ellefsen B, Holm-Pedersen P, Morse DE, Schroll M, Andersen BB, Waldemar G.

J Am Dent Assoc. 2009 Nov;140(11):1392-400.

PMID:
19884398
158.

Fast and robust multi-atlas segmentation of brain magnetic resonance images.

Lötjönen JM, Wolz R, Koikkalainen JR, Thurfjell L, Waldemar G, Soininen H, Rueckert D; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2010 Feb 1;49(3):2352-65. doi: 10.1016/j.neuroimage.2009.10.026. Epub 2009 Oct 24.

PMID:
19857578
159.

Effectiveness of donepezil in reducing clinical worsening in patients with mild-to-moderate alzheimer's disease.

Wilkinson D, Schindler R, Schwam E, Waldemar G, Jones RW, Gauthier S, Lopez OL, Cummings J, Xu Y, Feldman HH.

Dement Geriatr Cogn Disord. 2009;28(3):244-51. doi: 10.1159/000241877. Epub 2009 Sep 25.

160.

Association between subjective memory complaints and health care utilisation: a three-year follow up.

Waldorff FB, Siersma V, Waldemar G.

BMC Geriatr. 2009 Sep 23;9:43. doi: 10.1186/1471-2318-9-43.

161.

Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS study.

Teodorczuk A, Firbank MJ, Pantoni L, Poggesi A, Erkinjuntti T, Wallin A, Wahlund LO, Scheltens P, Waldemar G, Schrotter G, Ferro JM, Chabriat H, Bazner H, Visser M, Inzitari D, O'Brien JT; LADIS Group.

Psychol Med. 2010 Apr;40(4):603-10. doi: 10.1017/S0033291709990857. Epub 2009 Aug 12.

PMID:
19671212
162.

Genetic testing in familial AD and FTD: mutation and phenotype spectrum in a Danish cohort.

Lindquist SG, Schwartz M, Batbayli M, Waldemar G, Nielsen JE.

Clin Genet. 2009 Aug;76(2):205-9. doi: 10.1111/j.1399-0004.2009.01191.x. Epub 2009 Jul 29.

PMID:
19659892
163.

Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort.

Inzitari D, Pracucci G, Poggesi A, Carlucci G, Barkhof F, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Hennerici M, Langhorne P, O'Brien J, Scheltens P, Visser MC, Wahlund LO, Waldemar G, Wallin A, Pantoni L; LADIS Study Group.

BMJ. 2009 Jul 6;339:b2477. doi: 10.1136/bmj.b2477.

164.

Rates of cognitive change in Alzheimer disease: observations across a decade of placebo-controlled clinical trials with donepezil.

Jones RW, Schwam E, Wilkinson D, Waldemar G, Feldman HH, Zhang R, Albert K, Schindler R.

Alzheimer Dis Assoc Disord. 2009 Oct-Dec;23(4):357-64. doi: 10.1097/WAD.0b013e31819cd4be.

PMID:
19561444
165.

Diagnostic evaluation of dementia in the secondary health care sector.

Phung TK, Andersen BB, Kessing LV, Mortensen PB, Waldemar G.

Dement Geriatr Cogn Disord. 2009;27(6):534-42. doi: 10.1159/000223664. Epub 2009 Jun 9.

PMID:
19506375
166.

Validation of the Danish Addenbrooke's Cognitive Examination as a screening test in a memory clinic.

Stokholm J, Vogel A, Johannsen P, Waldemar G.

Dement Geriatr Cogn Disord. 2009;27(4):361-5. doi: 10.1159/000209271. Epub 2009 Mar 20.

PMID:
19299896
167.

Longitudinal cognitive decline in subcortical ischemic vascular disease--the LADIS Study.

Jokinen H, Kalska H, Ylikoski R, Madureira S, Verdelho A, van der Flier WM, Scheltens P, Barkhof F, Visser MC, Fazekas F, Schmidt R, O'Brien J, Waldemar G, Wallin A, Chabriat H, Pantoni L, Inzitari D, Erkinjuntti T; LADIS group.

Cerebrovasc Dis. 2009;27(4):384-91. doi: 10.1159/000207442. Epub 2009 Mar 10.

PMID:
19276621
168.

MRI-defined subcortical ischemic vascular disease: baseline clinical and neuropsychological findings. The LADIS Study.

Jokinen H, Kalska H, Ylikoski R, Madureira S, Verdelho A, Gouw A, Scheltens P, Barkhof F, Visser MC, Fazekas F, Schmidt R, O'Brien J, Hennerici M, Baezner H, Waldemar G, Wallin A, Chabriat H, Pantoni L, Inzitari D, Erkinjuntti T; LADIS group.

Cerebrovasc Dis. 2009;27(4):336-44. doi: 10.1159/000202010. Epub 2009 Feb 14.

PMID:
19218799
169.

Location of lacunar infarcts correlates with cognition in a sample of non-disabled subjects with age-related white-matter changes: the LADIS study.

Benisty S, Gouw AA, Porcher R, Madureira S, Hernandez K, Poggesi A, van der Flier WM, Van Straaten EC, Verdelho A, Ferro J, Pantoni L, Inzitari D, Barkhof F, Fazekas F, Chabriat H; LADIS Study group.

J Neurol Neurosurg Psychiatry. 2009 May;80(5):478-83. doi: 10.1136/jnnp.2008.160440. Epub 2009 Feb 11.

PMID:
19211595
170.

Deep frontal and periventricular age related white matter changes but not basal ganglia and infratentorial hyperintensities are associated with falls: cross sectional results from the LADIS study.

Blahak C, Baezner H, Pantoni L, Poggesi A, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Langhorne P, O'Brien J, Visser MC, Wahlund LO, Waldemar G, Wallin A, Inzitari D, Hennerici MG; LADIS Study Group.

J Neurol Neurosurg Psychiatry. 2009 Jun;80(6):608-13. doi: 10.1136/jnnp.2008.154633. Epub 2009 Feb 9.

PMID:
19204027
171.

Risks for central nervous system diseases among mobile phone subscribers: a Danish retrospective cohort study.

Schüz J, Waldemar G, Olsen JH, Johansen C.

PLoS One. 2009;4(2):e4389. doi: 10.1371/journal.pone.0004389. Epub 2009 Feb 5.

172.

Self-rated health in patients with mild Alzheimer's disease: baseline data from the Danish Alzheimer Intervention Study.

Waldorff FB, Nielsen AB, Waldemar G.

Arch Gerontol Geriatr. 2010 Jan-Feb;50(1):1-5. doi: 10.1016/j.archger.2008.12.010. Epub 2009 Feb 1.

PMID:
19181399
173.

Quantitation of brain tissue changes associated with white matter hyperintensities by diffusion-weighted and magnetization transfer imaging: the LADIS (Leukoaraiosis and Disability in the Elderly) study.

Ropele S, Seewann A, Gouw AA, van der Flier WM, Schmidt R, Pantoni L, Inzitari D, Erkinjuntti T, Scheltens P, Wahlund LO, Waldemar G, Chabriat H, Ferro J, Hennerici M, O'Brien J, Wallin A, Langhorne P, Visser MC, Barkhof F, Fazekas F; LADIS study group.

J Magn Reson Imaging. 2009 Feb;29(2):268-74. doi: 10.1002/jmri.21580.

PMID:
19161174
174.

Association between subjective memory complaints and nursing home placement: a four-year follow-up.

Waldorff FB, Siersma V, Waldemar G.

Int J Geriatr Psychiatry. 2009 Jun;24(6):602-9. doi: 10.1002/gps.2163.

PMID:
19058296
175.

Early counselling and support for patients with mild Alzheimer's disease and their caregivers: a qualitative study on outcome.

Sørensen LV, Waldorff FB, Waldemar G.

Aging Ment Health. 2008 Jul;12(4):444-50. doi: 10.1080/13607860802224342.

PMID:
18791891
176.

A novel presenilin 2 mutation (V393M) in early-onset dementia with profound language impairment.

Lindquist SG, Hasholt L, Bahl JM, Heegaard NH, Andersen BB, Nørremølle A, Stokholm J, Schwartz M, Batbayli M, Laursen H, Pardossi-Piquard R, Chen F, St George-Hyslop P, Waldemar G, Nielsen JE.

Eur J Neurol. 2008 Oct;15(10):1135-9. doi: 10.1111/j.1468-1331.2008.02256.x. Epub 2008 Aug 22.

PMID:
18727676
177.

On the etiology of incident brain lacunes: longitudinal observations from the LADIS study.

Gouw AA, van der Flier WM, Pantoni L, Inzitari D, Erkinjuntti T, Wahlund LO, Waldemar G, Schmidt R, Fazekas F, Scheltens P, Barkhof F; LADIS study group.

Stroke. 2008 Nov;39(11):3083-5. doi: 10.1161/STROKEAHA.108.521807. Epub 2008 Aug 14.

PMID:
18703801
178.

Urinary complaints in nondisabled elderly people with age-related white matter changes: the Leukoaraiosis And DISability (LADIS) Study.

Poggesi A, Pracucci G, Chabriat H, Erkinjuntti T, Fazekas F, Verdelho A, Hennerici M, Langhorne P, O'Brien J, Scheltens P, Visser MC, Crisby M, Waldemar G, Wallin A, Inzitari D, Pantoni L; Leukoaraiosis And DISability Study Group.

J Am Geriatr Soc. 2008 Sep;56(9):1638-43. doi: 10.1111/j.1532-5415.2008.01832.x. Epub 2008 Aug 4.

PMID:
18691285
179.

The pilot European Alzheimer's Disease Neuroimaging Initiative of the European Alzheimer's Disease Consortium.

Frisoni GB, Henneman WJ, Weiner MW, Scheltens P, Vellas B, Reynish E, Hudecova J, Hampel H, Burger K, Blennow K, Waldemar G, Johannsen P, Wahlund LO, Zito G, Rossini PM, Winblad B, Barkhof F; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2008 Jul;4(4):255-64. doi: 10.1016/j.jalz.2008.04.009.

180.

White matter changes contribute to corpus callosum atrophy in the elderly: the LADIS study.

Ryberg C, Rostrup E, Sjöstrand K, Paulson OB, Barkhof F, Scheltens P, van Straaten EC, Fazekas F, Schmidt R, Erkinjuntti T, Wahlund LO, Basile AM, Pantoni L, Inzitari D, Waldemar G; LADIS study group.

AJNR Am J Neuroradiol. 2008 Sep;29(8):1498-504. doi: 10.3174/ajnr.A1169. Epub 2008 Jun 12.

181.

Usability of cerebrospinal fluid biomarkers in a tertiary memory clinic.

Brandt C, Bahl JC, Heegaard NH, Waldemar G, Johannsen P.

Dement Geriatr Cogn Disord. 2008;25(6):553-8. doi: 10.1159/000137534. Epub 2008 Jun 9.

PMID:
18536519
182.

Consensus statement on genetic research in dementia.

Olde Rikkert MG, van der Vorm A, Burns A, Dekkers W, Robert P, Sartorius N, Selmes J, Stoppe G, Vernooij-Dassen M, Waldemar G.

Am J Alzheimers Dis Other Demen. 2008 Jun-Jul;23(3):262-6. doi: 10.1177/1533317508317817. Epub 2008 May 28.

PMID:
18509105
183.

Reduced parietooccipital white matter glutamine measured by proton magnetic resonance spectroscopy in treated graves' disease patients.

Danielsen ER, Elberling TV, Rasmussen AK, Dock J, Hørding M, Perrild H, Waldemar G, Feldt-Rasmussen U, Thomsen C.

J Clin Endocrinol Metab. 2008 Aug;93(8):3192-8. doi: 10.1210/jc.2007-2161. Epub 2008 May 20.

PMID:
18492756
184.

Segmentation of age-related white matter changes in a clinical multi-center study.

Dyrby TB, Rostrup E, Baaré WF, van Straaten EC, Barkhof F, Vrenken H, Ropele S, Schmidt R, Erkinjuntti T, Wahlund LO, Pantoni L, Inzitari D, Paulson OB, Hansen LK, Waldemar G; LADIS study group.

Neuroimage. 2008 Jun;41(2):335-45. doi: 10.1016/j.neuroimage.2008.02.024. Epub 2008 Feb 29.

PMID:
18394928
185.

Association of gait and balance disorders with age-related white matter changes: the LADIS study.

Baezner H, Blahak C, Poggesi A, Pantoni L, Inzitari D, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Langhorne P, O'Brien J, Scheltens P, Visser MC, Wahlund LO, Waldemar G, Wallin A, Hennerici MG; LADIS Study Group.

Neurology. 2008 Mar 18;70(12):935-42. doi: 10.1212/01.wnl.0000305959.46197.e6.

PMID:
18347315
186.

The diagnostic efficiency of biomarkers in sporadic Creutzfeldt-Jakob disease compared to Alzheimer's disease.

Bahl JM, Heegaard NH, Falkenhorst G, Laursen H, Høgenhaven H, Mølbak K, Jespersgaard C, Hougs L, Waldemar G, Johannsen P, Christiansen M.

Neurobiol Aging. 2009 Nov;30(11):1834-41. doi: 10.1016/j.neurobiolaging.2008.01.013. Epub 2008 Mar 12.

PMID:
18339451
187.

Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study.

Gouw AA, van der Flier WM, Fazekas F, van Straaten EC, Pantoni L, Poggesi A, Inzitari D, Erkinjuntti T, Wahlund LO, Waldemar G, Schmidt R, Scheltens P, Barkhof F; LADIS Study Group.

Stroke. 2008 May;39(5):1414-20. doi: 10.1161/STROKEAHA.107.498535. Epub 2008 Mar 6.

PMID:
18323505
188.

Alzheimer disease-like clinical phenotype in a family with FTDP-17 caused by a MAPT R406W mutation.

Lindquist SG, Holm IE, Schwartz M, Law I, Stokholm J, Batbayli M, Waldemar G, Nielsen JE.

Eur J Neurol. 2008 Apr;15(4):377-85. doi: 10.1111/j.1468-1331.2008.02069.x. Epub 2008 Feb 16.

PMID:
18284428
189.

Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease.

Waldemar G, Hyvärinen M, Josiassen MK, Kørner A, Lehto H, Wetterberg P.

Int J Geriatr Psychiatry. 2008 Sep;23(9):979-81. doi: 10.1002/gps.1979. No abstract available.

PMID:
18229874
190.

Reliability and sensitivity of visual scales versus volumetry for evaluating white matter hyperintensity progression.

Gouw AA, van der Flier WM, van Straaten EC, Pantoni L, Bastos-Leite AJ, Inzitari D, Erkinjuntti T, Wahlund LO, Ryberg C, Schmidt R, Fazekas F, Scheltens P, Barkhof F; LADIS study group.

Cerebrovasc Dis. 2008;25(3):247-53. doi: 10.1159/000113863. Epub 2008 Jan 24.

PMID:
18216467
191.

Atypical early-onset Alzheimer's disease caused by the Iranian APP mutation.

Lindquist SG, Nielsen JE, Stokholm J, Schwartz M, Batbayli M, Ballegaard M, Erdal J, Krabbe K, Waldemar G.

J Neurol Sci. 2008 May 15;268(1-2):124-30. doi: 10.1016/j.jns.2007.11.021. Epub 2008 Jan 9.

PMID:
18187157
192.

If you don't ask (about memory), they probably won't tell.

Waldorff FB, Rishoj S, Waldemar G.

J Fam Pract. 2008 Jan;57(1):41-4.

PMID:
18171569
193.

Sparse decomposition and modeling of anatomical shape variation.

Sjöstrand K, Rostrup E, Ryberg C, Larsen R, Studholme C, Baezner H, Ferro J, Fazekas F, Pantoni L, Inzitari D, Waldemar G; LADIS Study Group.

IEEE Trans Med Imaging. 2007 Dec;26(12):1625-35.

PMID:
18092733
194.

Self-perceived memory impairment and cognitive performance in an elderly independent population with age-related white matter changes.

Miranda B, Madureira S, Verdelho A, Ferro J, Pantoni L, Salvadori E, Chabriat H, Erkinjuntti T, Fazekas F, Hennerici M, O'Brien J, Scheltens P, Visser MC, Wahlund LO, Waldemar G, Wallin A, Inzitarion D; LADIS Study.

J Neurol Neurosurg Psychiatry. 2008 Aug;79(8):869-73. Epub 2007 Dec 12.

PMID:
18077477
195.

Caries prevalence in older persons with and without dementia.

Ellefsen B, Holm-Pedersen P, Morse DE, Schroll M, Andersen BB, Waldemar G.

J Am Geriatr Soc. 2008 Jan;56(1):59-67. Epub 2007 Nov 20.

PMID:
18028345
196.

A novel panel of cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer's disease versus normal aging and frontotemporal dementia.

Simonsen AH, McGuire J, Podust VN, Hagnelius NO, Nilsson TK, Kapaki E, Vassilopoulos D, Waldemar G.

Dement Geriatr Cogn Disord. 2007;24(6):434-40. Epub 2007 Oct 30.

PMID:
17971664
197.

Visual rating and ROI-based parametric analysis of rCBF SPECT in patients with mild or questionable dementia: a comparative study.

Høgh P, Teller AS, Hasselbalch S, Waldemar G.

Dement Geriatr Cogn Disord. 2007;24(6):429-33. Epub 2007 Oct 19.

PMID:
17952007
198.

Social participation in home-living patients with mild Alzheimer's disease.

Sørensen LV, Waldorff FB, Waldemar G.

Arch Gerontol Geriatr. 2008 Nov-Dec;47(3):291-301. Epub 2007 Oct 23.

PMID:
17936382
199.

White matter changes and late-life depressive symptoms: longitudinal study.

Teodorczuk A, O'Brien JT, Firbank MJ, Pantoni L, Poggesi A, Erkinjuntti T, Wallin A, Wahlund LO, Gouw A, Waldemar G, Schmidt R, Ferro JM, Chabriat H, Bäzner H, Inzitari D; LADIS Group.

Br J Psychiatry. 2007 Sep;191:212-7.

PMID:
17766760
200.

Validity of dementia diagnoses in the Danish hospital registers.

Phung TK, Andersen BB, Høgh P, Kessing LV, Mortensen PB, Waldemar G.

Dement Geriatr Cogn Disord. 2007;24(3):220-8. Epub 2007 Aug 10.

Supplemental Content

Loading ...
Support Center